Skip to main content
In The News

Herb Estreicher Quoted in Article on Options to Avoid CBI Hurdles In New TSCA Reporting Rule

Keller and Heckman Partner Herb Estreicher was quoted in the Inside TSCA article, “Industry Eyes Options To Avoid CBI Hurdles In New TSCA Reporting Rule.” The article discusses how the EPA’s new TSCA rule requiring companies to submit existing toxicity studies on 50 chemicals could create problems for firms that conducted such studies for European regulators but consider them confidential business information (CBI).

During Keller and Heckman’s July 14 TSCA 30/30 Webinar, Herb noted that the EPA’s newly finalized TSCA section 8(d) rule poses CBI issues for American companies.

“If you’re a U.S. company and you’re multinational and your foreign subsidiaries, or your own representatives, have developed health and safety studies for REACH or you’re part of a consortium for REACH registration and you have in U.S. files a copy of those studies, you have to turn it in,” even if it relies on data considered confidential in the United States, Herb said.

To read the full article, please click here. (subscription required)